Champions Oncology expands integrated radiopharmaceutical development with in-house SPECT/CT imaging
Champions Oncology said new molecular imaging capabilities link longitudinal radiopharmaceutical uptake to biodistribution, efficacy and clinically annotated PDX tumor biology within a single, U.S.-based workflow.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.